The research arm of the CF Center is housed in The Willard A. Bernbaum Cystic Fibrosis Research Center at Case School of Medicine.
The CF Research Center is directed by Pamela B. Davis, M.D., Ph.D., and has been continuously funded by the National Institutes of Health since 1964. Presently supported by a Core Center Grant from the NIDDK, the Center is one of 11 Cystic Fibrosis Foundation-designated Research Development Centers, and one of 18 CF Therapeutic Development Network Centers.
This group of investigators aspires to learn the fundamental errors in cystic fibrosis and their pathobiologic consequences and to devise new therapeutics to treat the disease and its complications. This program garners about $12 million per year in direct cystic fibrosis research support. The nuclear group of about 15 investigators whose primary efforts are in cystic fibrosis is joined by a group of over 25 investigators around the campus, some of whose laboratory effort is directed toward CF-related problems.
The Center focuses on translational research, and has brought discoveries made by the basic scientists to the patients through its clinical research program. The clinical research program is housed in the K.C. and Ginny Bryan Diagnostic Center at Rainbow.
Many therapies for CF that are in use today were developed and/or studied by the CF Center.